Evaluation of Targeted Next-Generation Sequencing for the Management of Patients Diagnosed with a Cancer of Unknown Primary

BACKGROUND: Cancer of unknown primary (CUP) comprises a heterogeneous collection of malignancies that are typically associated with a poor prognosis and a lack of effective treatment options. We retrospectively evaluated the clinical utility of targeted next-generation sequencing (NGS) among CUP pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fusco, Michael J, Knepper, Todd C, Balliu, Juliana, Del Cueto, Alex, Laborde, Jose M, Hooda, Sharjeel M, Brohl, Andrew S, Bui, Marilyn M, Hicks, J Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842368/
https://www.ncbi.nlm.nih.gov/pubmed/35305098
http://dx.doi.org/10.1093/oncolo/oyab014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842368/
https://www.ncbi.nlm.nih.gov/pubmed/35305098
http://dx.doi.org/10.1093/oncolo/oyab014

Ejemplares similares